On the Move: Advaxis Names New CEO

Share post:

Management Moves

Advaxis Inc., 305 College Road East, Princeton 08540. 609-452-9813. www.advaxis.com.

Advaxis, a biotech company focused on immunotherapy, has appointed Kenneth A. Berlin to be CEO, replacing interim CEO Anthony Lombardo. Former CEO Daniel J. O’Connor resigned in July, 2017.

Advaxis also reshuffled other top posts, appointing Andres Guiterrez executive vice president and chief medical officer. CFO Sara Bonstein will leave the company.

Before joining Advaxis, Berlin worked for Rosetta Genomics, where he has been CEO since 2009. He also held management positions at Johnson & Johnson and a subsidiary, Veridex LLC. He is a graduate of Princeton University and UCLA Law School.

Gutierrez, whose doctorate is from the National University of Mexico, was previously chief medical officer at Oncolytics Biotech and worked for SELLAS Life Sciences Group, Bristol-Myers Squibb, and other companies.

Deaths

Donald F. Barringer Jr., 85, on March 30. He was a research chemist for American Home Products (formerly American Cyanamid).

Mary Margaret Tierney, on April 19. She worked in the research division of Johnson & Johnson.

Sandra Helen Robbins, 73, on April 16. She owned and operated Ambest Surgical Supply Company in Ewing from 1975 until her retirement in 2015.

CE – US1

Related articles

Graffiti moves from city walls to museum halls

If all goes as planned, sometime in the next few years East State Street in Trenton will welcome...

Unruly Sounds: A festival for adventurous ears

Now in its 10th year, the Unruly Sounds Music Festival returns to Hinds Plaza in Princeton on Saturday,...

‘Teen Dad’ mixes family turmoil with moments of insight

Dudgeon can be tricky. It has to be pitched to the right degree, or the best instinct can play...

On Ramp: Week of Sept. 30

On Ramp is a guide to opportunities readers can act on now, from workshops, applications and classes to...